TOVEDESO

This brand name is authorized in Germany, Spain, Croatia

Active ingredients

The drug TOVEDESO contains one active pharmaceutical ingredient (API):

1 Desfesoterodine UNII 90Y3ELK3FB - DESFESOTERODINE SUCCINATE

Desfesoterodine is a competitive, specific muscarinic receptor antagonist. It is the primary active metabolite of fesoterodine, and regarded as main active pharmacological principle of fesoterodine; fesoterodine is considered as prodrug of desfesoterodine. The affinity of desfesoterodine for the muscarinic receptors is 2 orders of magnitude greater than that of fesoterodine. Read about Desfesoterodine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TOVEDESO Prolonged-release tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD13		G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 12447982, 12447999, 12448013, 12448042, 13754829, 13754835
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 82434, 82435
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-219578792, HR-H-862475317